Supernus Pharmaceutical’s stock declined following the release of disappointing Phase IIb trial results for SPN-820, an ...

the Geriatric Depression Scale (GDS), first created by Yesavage et al., has been tested and used extensively with the older population. It is a brief questionnaire in which participants are asked ...

Supernus Pharmaceuticals said on Tuesday its depression treatment trial failed to meet the main goal of reduction in depressive symptoms, sending its shares down 20% aftermarket. The company said the ...

The Alzheimer's Association revised the diagnostic criteria for Alzheimer disease (AD) and ADRD for clinicians in primary and specialty care.

After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...

The Hamilton Depression Rating Scale, for example, has 21 questions. The scores indicate the severity of depression among people who already have a diagnosis. The Beck Depression Inventory is ...

Third, depression diagnosis was largely inconsistent. Most studies relied on rating scales, such as the Center for Epidemiological Studies Depression (CES-D) Scale, the Beck Depression Inventory (BDI) ...

“If you’re comfortable talking about it with trusted friends or family members, getting a referral from someone you trust and ...

Just in time for Valentine’s Day, researchers at Stockholm University have created a new way to measure relationship ...

However, clinical trials provide some information that helps compare the two medications regarding how well they work for treating depression. Researchers measure the effectiveness of an ...

The primary efficacy outcome was the response to treatment, which was defined as an at least 50% decrease on a depression scale from baseline to the end of treatment. Secondary efficacy outcomes ...